Samsung Medical Center
Brain tumor treatment cost in the Republic of Korea is generally determined by the surgical approach and diagnostic complexity. A brain MRI with contrast typically costs $700 to $1,200, while primary brain tumor surgery runs from $19,500 to $46,000. Total expenses depend on the tumor stage, technology used, and hospital tier. Patients often find 30-50% savings compared to the US. Top cities for these procedures include Seoul and Incheon.
Typical Brain Tumor Treatment Costs in Republic of Korea
Bookimed Expert Insight: Patients requiring high-precision intervention should consider Samsung Medical Center for its advanced Novalis and IGRT technologies. For those seeking standardized digital safety, Seoul National University Bundang Hospital utilizes the BESTcare system to minimize medical errors. Complex multidisciplinary cases benefit from Asan Medical Center, which manages massive patient volumes with specialized oncology teams. JCI-accredited facilities like Severance Hospital offer premium care standards for international patients from the USA and UAE.
| Republic of Korea | Turkey | Austria | |
| Radiation therapy for brain tumor | from $29,729 | from $2,000 | from $15,000 |
| Proton-beam therapy | from $22,000 | from $70,000 | from $80,000 |
| Gamma Knife for brain tumor | from $11,891 | from $4,750 | from $25,000 |
| Gamma Knife | from $13,500 | from $6,300 | from $32,000 |
| CyberKnife for brain tumor | from $11,500 | from $4,750 | from $35,000 |
The doctor is a leading breast cancer specialist in South Korea and is recognized among the world’s top 100 gastric and breast cancer surgeons. The doctor pioneered breast conserving surgery in South Korea in 1986 and invented a unique stomach cancer surgery that minimizes the risk of gastroesophageal reflux disease. The doctor currently heads the Cancer Center for Women at Ewha Womans University Medical Center and has previously served as President of Konkuk University Hospital and Director of Korea Cancer Center Hospital. The doctor is also an active researcher in breast cancer diagnosis and management.
The doctor is a leading neurologist in South Korea, specializing in epilepsy treatment. Currently, the doctor serves as the Head of the Neurology Department at Yonsei Severance Hospital.
The doctor graduated from Yonsei University College of Medicine and is an active member of several professional organizations, including The Korean Epilepsy Society, The Korean Neurological Association, and The Korea Medical Association.
The doctor is a highly regarded pediatric and adult neurosurgeon in South Korea, specializing in endoscopic surgeries, brain tumor removal, and radiosurgery. The doctor is adept at treating both benign and malignant neoplasms, showcasing expertise in advanced neurosurgical techniques.
Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital (SNUH) are the premier institutions for brain tumor treatment in South Korea. These JCI-accredited and Newsweek-ranked facilities utilize advanced Novalis radiosurgery, Gamma Knife, and proton beam therapy to treat complex malignancies with high precision.
Bookimed Expert Insight: While Samsung Medical Center and SNUH are top-rated, SNU Bundang Hospital offers a unique safety advantage. It was South Korea's first fully digital hospital. Their BESTcare system significantly reduces medical errors in complex neurosurgery. This digital integration is the reason they maintain such high safety ratings despite serving 1,500,000 patients annually.
Patient Consensus: Patients recommend checking for English-speaking coordinators at SNUH early in the process. Many also note that securing local lodging in Seoul beforehand is vital for a smooth recovery period.
The 5-year survival rate for primary central nervous system tumors in South Korea is 86.4%. Clinical success rates for benign brain tumors reach 95% efficacy for surgical removal. Outcomes at high-volume centers often exceed global averages due to advanced intraoperative imaging and multidisciplinary protocols.
Bookimed Expert Insight: Patient volume is the most reliable predictor of success in Korea. Asan Medical Center treats over 2,500 inpatients daily and Seoul National University Hospital sees 10,700 patients. This massive scale allows surgeons at these JCI-accredited hubs to specialize in rare tumor subtypes that smaller clinics rarely encounter.
Patient Consensus: Patients emphasize that Korean neurosurgeons often achieve clean margins in complex glioblastoma cases where others could not. Many recommend prioritizing centers with proton therapy or intraoperative MRI for the best long-term remission results.
Korean hospitals use high-precision technologies like intraoperative MRI and 5-ALA fluorescence-guided surgery to maximize tumor removal. Non-surgical options include heavy ion therapy and ZAP-X gyroscopic radiosurgery. These tools allow surgeons to differentiate malignant cells from healthy tissue with sub-millimeter accuracy in JCI-accredited Seoul facilities.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital manage massive patient volumes, reaching up to 4,000,000 visits annually. This scale allows these centers to implement rare technologies like Novalis and heavy ion therapy much faster than smaller regional clinics. If you require specialized radiation, prioritize these high-volume Seoul centers for the most experienced technical teams.
Patient Consensus: Patients note that 5-ALA technology is more widely available in Korea than in many Western hospitals. They also emphasize that proton beam therapy significantly reduced side effects like hair loss and nausea compared to standard radiation.
Brain tumor surgery in the Republic of Korea typically requires a hospital stay of 4 to 7 days. Most patients return to normal activities within 6 to 12 weeks. Leading Seoul centers utilize minimally invasive techniques to accelerate recovery and minimize postoperative downtime.
Bookimed Expert Insight: High-volume centers like Asan Medical Center and Severance Hospital perform over 30,000 to 65,000 annual operations. Our data shows these institutions prioritize early rehabilitation protocols immediately after the ICU phase. This aggressive mobilization often reduces total hospital stays by 2 days compared to global averages. Patients at Samsung Medical Center benefit from presidential-standard care, which often includes integrated digital monitoring to catch postoperative edema early.
Patient Consensus: Patients note that while the physical incision heals quickly, brain fog and fatigue often linger for several months. Many emphasize that a temporary slump during steroid tapering at 4 weeks is a normal part of the process.
Patients with inoperable brain tumors in South Korea have access to advanced non-surgical treatments like Gamma Knife, CyberKnife, and proton-beam therapy. These technologies deliver high-precision radiation to delicate areas like the brainstem. Systemic medical therapies and dedicated tumor-treating fields further expand treatment options.
Bookimed Expert Insight: Analysis of South Korean oncology centers shows a clear preference for digital integration to enhance safety. Facilities like Samsung Medical Center and Seoul National University Hospital utilize IGRT and AI-driven imaging. This digitalization allows specialists to manage high volumes, with some treating over 10,000 patients daily while maintaining precision.
Patient Consensus: Patients highlight that proton therapy in Korea often involves shorter wait times than in the US. They note that stereotactic radiosurgery is a preferred first-line choice for small, hard-to-reach tumors.